DARS2 and ovarian cancer: The enzyme Aspartyl tRNA synthetase 2 (DARS2) is a mitochondrial enzyme [6], and previous studies have reported its crucial role in the development of bladder cancer [7], lung adenocarcinoma [8, 9], ovarian cancer [10], and hepatocarcinogenesis [11].